Show simple item record

dc.contributor.authorNajib, Omaima N.
dc.contributor.authorMartin, Gary P
dc.contributor.authorKirton, Stewart
dc.contributor.authorSallam, Al-Sayed
dc.contributor.authorMurnane, Darragh
dc.date.accessioned2016-12-19T18:09:49Z
dc.date.available2016-12-19T18:09:49Z
dc.date.issued2016-06-15
dc.identifier.citationNajib , O N , Martin , G P , Kirton , S , Sallam , A-S & Murnane , D 2016 , ' Establishing the importance of oil-membrane interactions on the transmembrane diffusion of physicochemically diverse compounds ' , International Journal of Pharmaceutics , vol. 506 , no. 1-2 , pp. 429-437 . https://doi.org/10.1016/j.ijpharm.2016.03.020
dc.identifier.issn0378-5173
dc.identifier.urihttp://hdl.handle.net/2299/17449
dc.description© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This is a pre-copyedited, author produced PDF of an article accepted for publication in International Journal of Phrmaceutics following peer review. The final, definitive version of this paper Vol 56 (1-2): 429-437 , first published online March 21, 2016, is available on line at doi: 10.1016/j.ijpharm.2016.03.020
dc.description.abstractThe diffusion process through a non-porous barrier membrane depends on the properties of the drug, vehicle and membrane. The aim of the current study was to investigate whether a series of oily vehicles might have the potential to interact to varying degrees with synthetic membranes and to determine whether any such interaction might affect the permeation of co-formulated permeants: methylparaben (MP); butylparaben (BP) or caffeine (CF). The oils (isopropyl myristate (IPM), isohexadecane (IHD), hexadecane (HD), oleic acid (OA) and liquid paraffin (LP)) and membranes (silicone, high density polyethylene and polyurethane) employed in the study were selected such that they displayed a range of different structural, and physicochemical properties. Diffusion studies showed that many of the vehicles were not inert and did interact with the membranes resulting in a modification of the permeants’ flux when corrected for membrane thickness (e.g. normalized flux of MP increased from 1.25 ± 0.13 μg cm−1 h−1 in LP to 17.94 ± 0.25 μg cm−1 h−1in IPM). The oils were sorbed differently to membranes (range of weight gain: 2.2 ± 0.2% for polyurethane with LP to 105.6 ± 1.1% for silicone with IHD). Membrane interaction was apparently dependent upon the physicochemical properties including; size, shape, flexibility and the Hansen solubility parameter values of both the membranes and oils. Sorbed oils resulted in modified permeant diffusion through the membranes. No simple correlation was found to exist between the Hansen solubility parameters of the oils or swelling of the membrane and the normalized fluxes of the three compounds investigated. More sophisticated modelling would appear to be required to delineate and quantify the key molecular parameters of membrane, permeant and vehicle compatibility and their interactions of relevance to membrane permeation.en
dc.format.extent9
dc.format.extent1194224
dc.language.isoeng
dc.relation.ispartofInternational Journal of Pharmaceutics
dc.subjectDermal drug delivery
dc.subjectMembrane diffusion
dc.subjectPhysicochemistry
dc.subjectDrug transport
dc.subjectPermeation
dc.subjectCosmetic oils
dc.titleEstablishing the importance of oil-membrane interactions on the transmembrane diffusion of physicochemically diverse compoundsen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionPharmaceutics
dc.contributor.institutionAirway Group
dc.contributor.institutionPharmaceutical Analysis and Product Characterisation
dc.contributor.institutionNatural Product Chemistry and Drug Design
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.description.statusPeer reviewed
dc.date.embargoedUntil2017-03-21
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0378517316302198
rioxxterms.versionofrecord10.1016/j.ijpharm.2016.03.020
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record